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Abstract
Objective: Investigate differences between athletes that responded 
(improved performance) compared to those that did not, after a 20-
day “live high-train low” (LHTL) altitude training camp. 
Methods: Ten elite triathletes completed 20 days of live high 
(1545-1650 m), train low (300 m) training. The athletes underwent 
(i), two 800-m swimming time trials at sea-level (1 week prior to and 
1 week after the altitude camp) and (ii) two 10-min standardised 
submaximal cycling tests at altitude on day 1 and day 20 of the 
altitude camp. Acute mountain sickness (AMS) was also measured 
during the camp. Based on their 800-m swimming time trial 
performances, athletes were divided into responders (improved by 
3.2 ± 2.2%, mean ± SD, n=6) and non-responders (decreased by 
1.8 ± 1.2%, n=4). 
Results: Compared to non-responders, the responders had 
lower exercise heart rates (-6.3 ± 7.8%, mean ± 90% CL, and 
higher oxygen saturations (1.2 ± 1.3%) at the end of the 10-min 
submaximal test after the camp. Compared to the responders, the 
non-responders had substantially higher VE and VE/VO2 during 
the submaximal test on day 1 of the altitude training camp, and a 
substantially higher RER during the submaximal test on day 20 of 
the camp. As a result of the altitude training, exercise economy of 
the non-responders compared to the responders deteriorated (i.e., 
non-responders required more oxygen per watt). Non-responders 
were 3.0 times (90% CL=0.5-16.6) more likely to suffer symptoms 
of acute mountain sickness during first 5 days of altitude compared 
to responders. 
Conclusion: Changes in SpO2, heart rate and some respiratory 
variables during exercise and resting AMS scores may help 
determine athletes that respond to LHTL altitude training camps 
from athletes that fail to respond to such training.
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Introduction
The LHTL protocol (live at high altitude and train at or near 
sea level) has been shown to be the most effective altitude training 
method for improving sea level performance among athletes [1,2] 
and remains a very popular training method for elite athletes [3]. 
One of the key issues in the final outcome of LHTL altitude training 
is the problem of ‘non-responders’. Some athletes thrive on altitude 
training and their performance improves, while others either fail to 
improve or suffer performance decline. It is currently not known why 
some athletes ‘respond’ to altitude and why others do not. 
Many researchers have investigated the individual variability in 
athletes’ response to altitude training. Investigators have suggested 
that some athletes experience a better haematological response at 
altitude than others [4-6], which may help reduce stress by allowing 
more oxygen to be transported to the working muscle. Chapman 
et al. found that performance improvement was associated with 
increased Erythropoietin (Epo) which increased total red cell volume 
and subsequently VO2max after a 28-day altitude training camp in 
responders [5]. However, wide inter-individual variability has been 
found in erythropoietic response to altitude training which might not 
identify those elite athletes who respond to altitude training [7]. For 
example, Ge et al. reported individual responses in Epo ranged from 
-41 to 400% from baseline after 24 hours at 2800 m [8]. 
Recently researchers have searched for genetic determinants of 
the individual variability of the Epo response to altitude which may 
help explain why some athletes respond and some do not. While some 
researchers have identified specific genes associated with successful 
human existence at high altitude [9], others have reported little 
association between the proposed genes involved in Epo regulation 
and Epo response to hypoxia [10]. In addition, Hypoxia Inducible 
Factor (HIF-1) gene expression quantification after a 3-h hypoxia 
test performed before training was unable to predict poor and good 
responder athletes to the living high-training low model [11]. Others 
have suggested that individual difference in the tolerance to hypoxia 
may be explained by an increased Acute Mountain Sickness (AMS) 
incidence [12], which subsequently affects training and adaptation 
and ultimately performance. In short, the differentiation between 
responders and non-responders is probably based on many factors 
including genetic predisposition [13], automatic nervous system 
adaptation [14], hypoxia-induced ventilator drive [15], underlying 
individual fitness levels, fatigue recovery and motivation [16]. 
It is clear that there is considerable individual variation in the 
physiological responses of athletes using altitude training, which 
makes the prediction of responders and non-responders very difficult. 
Some researchers have recently suggested screening individuals prior 
to altitude training may help identify those that may be negatively 
affected by such training [6], however pre-altitude testing is not 
always possible particularly on national squads that are commonly 
dispersed around the world.
The aim of the current project was to investigate different 
physiological (i.e., oxygen saturation, oxygen consumption, heart 
rate and performance responses) and subjective (acute mountain 
sickness (AMS), rate of perceived exertion (RPE)) responses of 
athletes undergoing training at a 20-day altitude camp in the hope 
of identifying possible parameters that may help identify responders 
from non-responders.
Methodology
Altitude 
When deciding on an altitude to conduct a live-high train-low 
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model of training it is important to consider the effects of using 
an altitude that is high enough to produce a positive physiological 
response, but not so high as to reduce the recovery from training 
or cause unwanted clinical effects (nausea, dehydration etc.). A 
number of studies have suggested an altitude between 2000 and 
2500 m is ideal for live-high train-low training, based mainly on the 
haematological response [8,17]. However recent research suggests 
athletes can improve performance after altitude training without 
positive haematological adaptation [18]. Therefore basing the altitude 
training threshold purely on haematological changes is probably 
unwise [19,20]. The altitude of 1545-1650 m used in this study was 
based mainly on practical reasons (a convenient ski lodge with all the 
necessary essentials was available at this altitude), but was also backed 
by contemporary research. Low to moderate altitude has previously 
been shown to produce significant improvements in sea level swim 
time trial performance (~1.9%) [21]. Indeed, in a recent study 
proclaiming the use of altitudes between 2000-2500 m the authors also 
found positive physiological (red cell mass volume ~7%,VO2 ~2%) 
and performance (~1%) effects for athletes on immediate return to 
sea level after living at 1754 m [17]; something that is not uncommon 
at these low altitudes (1200 m) [22]. Performance improvements of 
this magnitude would indicate meaningful effects for the very elite 
triathletes involved in this study [23].
Subjects
Ten elite triathletes were recruited from the New Zealand 
Academy of Sport development programme. All of the subjects (6 
males and 4 females) who participated in the present study were 
international level athletes. The research was conducted over the 
summer period at Snow Farm (1545-1650 m), Wanaka, New Zealand. 
The study was approved by the Lincoln University Human Ethics 
Committee. Informed, voluntary, written consent was obtained from 
each subject prior to the start of the study. All subjects were free from 
injury, lived at sea level and had not been residents at altitude within 
the past 6 months. Subject characteristics and baseline measures of 
training are presented in Table 1.
Study design 
The elite triathletes slept and stayed at the Snow Farm (1545-
1650 m) and travelled to train at Wanaka (300 m) for approximately 
2.7 ± 1.2 hour/day for 20 days during the camp. All subjects performed 
two exercise tests; swimming and submaximal cycling on day 1 and 
day 20 of the training camp. During the altitude camp, five subjects 
were randomly selected to receive iron supplementation of 1 capsule a 
day (controlled release iron tablets containing dried Ferrous Sulphate 
BP 325 mg (equivalent to 105 mg element iron), vitamin C 500 mg as 
sodium ascorbate (FERROGRAD® C, Abbott Laboratories (NZ) Ltd, 
Naenae)), while five subjects received a placebo. No contraindications 
for iron supplementation were found in any participants prior to the 
training camp, with all subjects showing normal iron, haemoglobin 
and ferritin levels (19.6 ± 4.4 umol.L-1, 145.0 g.L-1 ± 7.8, 82.9 ± 
30.9 ug.L-1 mean ± SD for serum iron, haemoglobin and ferritin 
respectively). Retrospectively, based on their 800-m swim time trial, 
athletes were divided into responders (n=6) who had positive results 
(decreased their swimming time) and non-responders (n=4) who had 
negative results (increased their swimming time). 
Testing
Maximal exercise test: Performance was assessed by individual 
800-m timed swim trials in a standard 25-m pool near sea level. Time 
trials were performed at the same time each day with similar water 
temperature and brands of swimming costumes. Subjects completed 
a standardised 10-15 min warm-up with stretching prior to the swim. 
Subjects were instructed to try to achieve the best time possible during 
the swim, but were not provided with feedback on time or pace.
Submaximal exercise test: The submaximal cycling test was 
performed at altitude on each athlete’s own bicycle set up on a 
stationary ergometer (Cycle Ops Fluid 2, Madison, WI, USA) at the 
same time of day, on the first and last day of the altitude camp. Subjects 
performed the 10-min submaximal test at 250 W (for males) or 200 W 
(for females) during which heart rate (S610; Polar, Kempele, Finland), 
oxygen saturation (Sport-Stat, Nonin Medical, Minneapolis, MN) and 
rate of perceived exertion were recorded every minute. In addition, 
ventilation and expired gases were measured breath-by-breath using 
a portable gas exchange system (MetaMax® 3B; Cortex Biophysik, 
Leipzig, Germany). Before testing, the gas analyser was calibrated 
for volume (Hans Rudolph 5530 3 L syringe; Kansas City, MO, USA) 
and gas composition (15% O2 and 5% CO2). Oxygen consumption ( V
O2), minute ventilation ( V E), and respiratory exchange ratio (RER) 
were measured continuously during the submaximal test, however 
only the mean of the final 5 minutes of the test was used for analysis 
to ensure steady state measures. Face masks (Hans Rudolph, Kansas 
City, MO, USA) with small dead spaces (approximately 70 mL) were 
fitted to participants allowing simultaneous breathing at the mouth 
and nose. Subjects performed a 10-minute, self-selected warm-up 
before the test followed by a 5-minute self-selected warm-down.
Ongoing monitoring 
All of the subjects were monitored daily for morning heart rate, 
body weight, oxygen saturation and subjective perception of fatigue, 
muscle soreness, sleep, stress and training performance. The Lake 
Louise Acute Mountain Sickness Score and training intensity and 
volume were recorded throughout the camp.
Training
Training loads were calculated via the training impulse (TRIMP) 
method [24], which was expressed as product of stress (duration of 
activity) and strain (a 5-point Likert-type scale based on exercise 
heart rate; easy=1, steady=2, moderately hard=3, hard=4, very 
hard=5). The heart rate training zones were identified initially from 
laboratory based cycling and running lactate tests, and confirmed 
or adjusted by training sessions performed in the field prior to the 
altitude training camp. The following training zones were established; 
easy, corresponded to heart rates where lactate was ≤ resting lactate 
Variables Responders(n = 6)
Non-responders
(n = 4)
Age (y) 23.5 ± 4.2 21.0 ± 2.0
Body mass (kg) 64.7 ± 7.4 66.1 ± 7.4
Height (cm) 173.2 ± 6.4 175.2 ± 5.1
Gender Male 3; Female 3 Male 3; Female 1
BMI (kg.m-2) 21.8 ± 1.3 21.8 ± 3.1
Swim Training (Trimp.d-1) 163.7 ± 69.5 161.7 ± 68.3
Bike Training (Trimp.d-1) 218.3 ± 127.3 184.3 ± 84.8
Run Training (Trimp.d-1) 137.1 ± 96.1 113.9 ± 73.4
Total Training (Trimp.d-1) 519.0 ± 41.4 459.8 ± 35.9
Table 1: Characteristics and training workloads of athletes in the two training 
groups.
Note: Data are mean ± SD. No substantial difference between groups.
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concentration, steady=heart rate at the first lactate turn point, 
moderately hard=heart rate range between the first and second lactate 
turn point, hard=heart rates that matched the second lactate turn 
point (~4 mmol.L-1) and very hard=heart rate from the second lactate 
turn point to maximum heart rate. 
Data analysis 
All data are means and standard deviations (SD) within and 
between groups and subjects. We used the baseline data as a 
covariate in the analysis to adjust for any differences between groups 
at baseline. We used a contemporary statistical approach because 
small performance changes can be beneficial for elite athletes [25], 
whereas conventional statistics can be less sensitive to such small 
but worthwhile changes. Specifically, we used magnitude-based 
inferences about effect sizes, and then to make inferences about true 
(population) values of the effect, the uncertainty in the effect was 
expressed as 90% confidence limits (CL). The probability that the true 
value of the effect was practically negative, trivial, or positive accounted 
for the observed difference, and typical error of measurement [26]. 
The natural logarithm of each measure was analysed to reduce any 
effects from non-uniformity errors and then back-transformed. For 
the physiological variables, the value was determined by multiplying 
the baseline between-subject standard deviation by Cohen’s value 
of the smallest worthwhile effect of 0.2 [27]. The unequal variances 
t statistic was used to analyse differences in the mean change between 
groups. The difference in the proportion of responders taking iron 
supplementation and having Acute Mountain Sickness were analysed 
using the general linear modelling procedure (Proc Genmod version 
8.2, SAS Institute Inc., Cary, N.C.) and given as relative risk. The 
smallest worthwhile change in 800-m performance was assumed to be 
a reduction or increase in performance time of more than 1.0%, based 
on previous research into elite athletes competitive performance [23].
Results
Based on any improvement (change) in the sea level 800-m, 
swim time trial, all of the subjects were retrospectively grouped as 
responders and non-responders (Figure 1). Responders’ performance 
improved by 3.2 ± 2.2%, mean ± SD and non-responders performance 
decreased by 1.8 ± 1.2%, therefore compared to non-responders, the 
responders improved performance on average by 5.0% (90% CL ± 
2.2%) as a result of the 20-day altitude training camp.
Physiological variables
Heart rate and SpO2: Compared to non-responders, responders 
heart rate at the end of the 5 and 10 minute periods of the submaximal 
cycle test as a result of the altitude camp were lower (-3.8 ± 4.4% 
and -6.3 ± 7.8%, mean ± 90% CL, respectively). Relative to the non-
responders, the responders also showed a substantial increase in SpO2 
at the start (0 minute 2.1 ± 1.7, mean ± 90% CL) and at the end of the 
10 minute submaximal cycle test (1.2 ± 1.3%). Responders SpO2 at 
the end of the 5th minute of the cycle was elevated compared to non-
responders but was not substantially different (Table 2). Compared to 
the responders, the non-responders had substantially higher V E and 
V E/ V O2 (ventilatory equivalent) measures during the submaximal 
test on day 1 of the altitude training camp, and a substantially higher 
RER during the submaximal test on day 20 of the camp (Table 3). 
As a result of the 20-day altitude training camp, the economy (i.e. 
power (Watts) per litre of oxygen consumed) of the non-responders 
compared to the responders deteriorated (i.e. non-responders 
required more oxygen per watt of work completed). Compared to 
non-responders, responders showed overall improvement SpO2 per 
wattage during the 10 minute submaximal cycle test (responders 3.6 
± 1.5% and non-responders 1.4 ± 1.2% mean ± SD). 
Iron supplementation: Interestingly, 4 of the 6 responders who 
improved their swimming performance were taking iron tablets 
during the altitude camp while 1 of the 4 non-responders were 
taking iron. In other words, those participants that underwent iron 
supplementation were 4.0 times (90% CL=1.3-12.8) more likely 
to improve performance than participants who did not take the 
supplement.
 Subjective variables
Compared to non-responders, responders were more likely 
to have a lower RPE score before (0 min) and after (end of 5 min 
recovery) the 10-min submaximal cycle tests (Table 3). Changes to 
RPE score during the 10-min cycle test were unclear.
There were substantial differences in morning SpO2 at day 1, 2 
and 3 between responders and non-responders (1.1 ± 2.0 %, 1.0 ± 
1.1 % and 0.8 ± 0.8 %, mean ± 90% CL, respectively). The morning 
heart rates were not substantially different between groups. The 
body weights in non-responders tended to decline from day 1 to day 
6 (no substantial difference from day 1) of altitude camp, and then 
plateau. Compared to responders, non-responders body weights were 
Figure 1: Individual data for 800-m swimming time trial (sec) in the responders 
and non-responders 1 week before (baseline) and 1 week after (post-test) 
altitude camp.
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substantially higher at day 1, 2 and 3 (5.8 ± 7.6 kg, 6.0 ± 7.5 kg, 6.0 ± 
7.6, mean ± 90% CL) of camp (Figure 2). 
Subjective scores for fatigue, muscle soreness, the Lake Louise 
Acute Mountain Sickness (LL-AMS) score and training performance 
are presented in Figure 3. The scores for fatigue and muscle soreness 
in non-responders showed mostly higher scores from day 1 to day 
20 compared to responders during the camp. For the LL-AMS, 
non-responders were 3.0 times (90% CL=0.5-16.6) more likely to 
suffer symptoms of AMS during first 5 days of altitude compared 
to responders. Specifically, at day 3 and 5, the mean AMS score in 
responders and non-responders were substantially different (2.3 ± 2.2, 
1.2 ± 1.8, mean ± 90% CL). Compared to non-responders, responders 
also indicated training performance was better particularly at day 
2, 10 and 15 (0.8 ± 1.0, 0.5 ± 0.6 and 0.8 ± 0.6, mean ± 90% CL, 
respectively).
Discussion
This study had two main findings. First, in response to the 20-day 
camp utilizing a LHTL protocol, responders had a substantially higher 
exercise SpO2 and lower exercise HR during a submaximal cycle 
test at altitude. Second, based on the Lake Louise Acute Mountain 
Sickness Score and the subjective perception scores of fatigue and 
muscle soreness during altitude training, it seems that responders 
coped with the LHTL protocol stress better than non-responders. 
An unexpected but potentially clinically useful finding was that non-
responders had consistently higher submaximal exercise RPE scores 
compared to responders (Table 4). 
 It is obvious from our results that the LHTL strategy is not 
effective for all athletes trying to improve sea-level performance. 
The mechanisms that contribute to individual variability in 
responders and non-responders are difficult to elucidate. Large inter-
individual variations in physiological responses to hypoxia have 
been reported, including, erythropoietin release [7] and maximum 
oxygen consumption [5]. Previous research has suggested a possible 
reason for performance variation with altitude training may be 
differences in gene expression [11,13] and may also relate to different 
stress thresholds within athletes [14]. Such variation may create 
an environment where some athletes might find the demand of 
coping with altitude in addition to normal training too stressful and 
maladaption may ensue, while others may thrive, giving rise to the 
performance variation observed. 
Physiological variables
Our study, found responders showed a substantial improvement 
in SpO2 at 0 min (or just prior to the test after 5 min standardised 
warm up) and in the last minute of submaximal cycle test compared 
to non-responders. In fact, during the submaximal cycle test, all 
athletes decreased their SpO2 to varying degrees which underscores 
the individual variability in physiological variables among elite 
athletes. Some researchers have reported significant increases in 
arterial oxyheamoglobin saturation which contributed to significant 
improvement in exercise performance with LHTL (1800-1900 m) 
via supplemental oxygen [28]. Similar findings have been noted 
among climbers after a 21-day expedition to 6,194 m [29]. However, 
these two studies did not separate responders from non-responders. 
Chapman et al. reviewed the evidence for individual responses to 
LHTL training and found that athletes that desaturate more during 
Mean Changes (%) Chances that true differences  are substantiala
Responders
(n = 6)
Non-Responders
(n = 4) Difference;
b ± 90% CL % Qualitative inference
Body weight 1.3 ± 0.6 0.3 ± 2.9 1.9  6.4 42 Unclear
HR 0 min 4.8 ± 6.6 10.3 ± 14.7 -6.8  18.3 68 Unclear
HR 5 min -4.7 ± 3.9 -1.0 ± 10.6 -3.8 ± 4.4 86 Likely
HR 10 min -2.5 ± 8.5 3.3 ± 12.6 -6.3 ± 7.8 87 Likely
SpO2 0 min 1.5 ± 2.8 -0.8 ± 2.0 2.1  1.7 95 Very likely
SpO2 5 min 4.0 ± 3.8 2.3 ± 0.9 1.4 ± 2.4 73 Unclear
SpO2 10 min 3.3 ± 1.5 2.3 ± 0.5 1.2  1.3 83 Likely
Data are mean ± SD. Day 1 of altitude training, Day 20 of altitude training; HR 0 min, heart rate  after 5 min warm up prior to 10-min submaximal cycle test; HR 
5 min, heart rate at 5th min during the 10-min submaximal cycle test; HR 10 min, heart rate during last minute of 10-min submaximal cycle test; SpO2 0 min, arterial 
oxyhemoglobin saturation  after 5 min warm up prior to 10-min submaximal cycle test; SpO2 5 min, arterial oxyhemoglobin saturation at 5
th min during the 10-min 
submaximal cycle test; SpO2 10 min, arterial oxyhemoglobin saturation during last minute of 10-min submaximal cycle test. 
 aBased on the smallest substantial change 
of 1.0% for all measures. ± 90% CL: add and subtract this number to the mean effect to obtain confidence limits for the true difference. bDifferences between groups 
after adjustment for baseline measures in both groups.
Table 2: Mean changes in physiological measures during a 10-min submaximal cycle test (day 20 minus day 1) and chances that the differences represent real 
changes.
Responders (n = 6) Non-Responders (n = 4)
Day 1 Day 20 Day 1 Day 20
V E (L.min-1) 68.5 ± 19.9 79.6 ± 24.3 93.1 ± 16.6* 95.5 ± 30.2
V O2 (L.min-1)
1.7 ± 0.5 2.0 ± 0.7 1.3 ± 0.6 2.6 ± 0.7
RER 0.94 ± 0.02 0.84 ± 0.03 0.95 ± 0.02 0.87 ± 0.04˄
V E/ V O2 (L.L-1)
40.2 ± 14.1 40.8 ± 9.9 76.6 ± 38.8* 52.5 ± 13.3
Economy (Watt.L-1) 132.2 ± 42.2 127.3 ± 40.7 209.6 ± 86.3* 94.2 ± 17.2†
Data are mean ± SD. *Substantially different between responders and non-responders at day 1 of training, ˄Substantially different between responders and non-
responders at day 20 of training, †Substantially different between responders and non-responders over the course of the training (day 20 minus day 1). Based on the 
smallest substantial change of 0.2 for all measures.
Table 3: Mean changes in respiratory variables over the last 5 minutes of a 10-min submaximal cycle test conducted on day 1 and day 20 of altitude training.
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exercise (at sea level or altitude) tend to have difficulty in adapting 
to altitude training while those that maintain adequate oxygen 
saturation respond better [6]. The relative increase (compared to 
non-responders) in the current study in SpO2 in responders (which 
corroborates the theory of Chapman et al. could be explained 
in part by increased haemoglobin concentration [30], enhanced 
erythropoietic response [7,31], which may result in increased red 
cell volume [4] and subsequently increased arterial oxygen content. 
Weil et al. noted a graded response such that an increase in red cell 
mass was proportional to oxyhaemoglobin saturation at sea level and 
altitude [32]. This may suggest a haematological aspect is involved 
in the beneficial adaptation to altitude. The chronic hypoxic stress 
facilitates increased red cell production (when adequate iron level is 
available) which leads to an increase haemoglobin available to carry 
oxygen to muscle cells (and subsequently increase SpO2).
Relative to non-responders, the heart rate of responders at 5 min 
and 10 min during the submaximal cycling test were substantially 
Figure 2: Daily monitoring for HR, SpO2 and body weight throughout the 
altitude camp. Close circles represent responders and open circles represent 
non-responders. *Substantial difference from non-responders. Values are 
mean ± SD.
Figure 3: Subjective fatigue, muscle soreness, Lake Louise Acute Mountain 
Sickness and training performance score in both responders (close circles) 
and non-responders (open circles) throughout the altitude camp. 
Note: *Substantial difference from non-responders. Values are mean ± SD.
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lower. In addition, responders had lower V E, RER, V E/ V O2, but 
better economy (post training camp) and higher relative SpO2 to 
wattage ratio than non-responders. This may imply that responders 
have a greater ability to maintain training workload during altitude 
camps. These findings are consistent with the results of the Chapman 
et al. study, where individual variability in the response to altitude 
training was accounted for by maintenance of training intensity 
and oxygen uptake values [5]. Previous work has also found similar 
improvements in exercise economy after altitude training based 
at higher (2500-3500 m) and lower (1200 m) altitudes [22]. We 
suggest that the higher exercise SpO2 in responders reflects higher 
arterial partial pressure of oxygen. Responders are therefore able 
to train at higher intensities without delving into anaerobic energy 
systems and subsequently fatigue and therefore acquire performance 
improvement. The non-responders on the other hand, cannot 
maintain adequate oxygen levels in the blood resulting in lower SpO2 
causing an increase in heart rate and V E. In addition, the lower levels 
of oxygen require a higher reliance on anaerobic metabolic processes, 
thereby elevating RER. The other possible cause for lower heart rates 
in responders during submaximal exercise may be due to increased 
vagal dominance [14], or to the elevation of red cell volume, therefore 
blood volume, stroke volume and ultimately cardiac output, which 
subsequently decreases heart rate. A recent study demonstrated that 
red cell volume remained elevated in responders after 2 weeks of 
altitude training, while non-responders red cell volume returned to 
their original levels [4]. However, such linkages between heart rate 
changes and response to altitude require further research to confirm 
findings.
Subjective variables
We observed that non-responders found the submaximal 
exercise test subjectively harder (high RPE score) than responders. 
Svedenhag et al. found that 2 weeks of altitude (2000 m) training 
improved RPE during exercise compared to sea-level training [33] 
but there are currently no studies comparing the perceived exertion 
of responders with non-responders. Bailey et al. also reported that 
4 weeks of altitude training (1500-2000 m) improved RPE when 
performing a submaximal exercise test at sea-level in elite distance 
runners [34]. A high correlation between RPE and HR was reported 
by Borg et al. in a variety of work tasks (cycling and treadmill) and 
under varying exercise conditions (moderate to heavy intensity) [35]. 
It seems a major influence on RPE scores is the build-up of blood 
lactate and hydrogen ions due to insufficient aerobic processes to 
meet the demands of heavy exercise [36]. We postulate that non-
responders are required to meet the energy demands of exercise 
at altitude through greater anaerobic means thus pushing up RPE, 
heart rate and RER, however, this hypothesis is speculation as these 
measures were not taken in this study and further studies are required 
to substantiate this argument. 
Acute mountain sickness (AMS) and the subjective perception 
score on fatigue, muscle soreness and training performance 
demonstrated that non-responders were not acclimatizing to the 
extra stress of training and hypoxia to the same extent as responders. 
Fatigue and muscle soreness scores indicated more stress after 
24-h exposure to altitude (day 1) in non-responders compared to 
responders. Overall non-responders had a higher daily score on most 
days of the altitude training camp in all of the subjective parameters. 
Previous research suggested that AMS sufferers have lower resting 
pain thresholds and subsequently increased exercise-induced muscle 
soreness which was caused by free-radical-mediated skeletal muscle 
damage [37]. In short, low AMS and subjective perception scores of 
fatigue and muscle soreness could be a sign of those who adapt well 
to moderate altitude. It seems the responders adapt to extra stress of 
training at altitude whereas the non-responders find the extra stress 
of training and altitude too much and subsequently maladapt. Such 
changes in these subjective measures of participants may be useful for 
coaches as a detection mechanism for those athletes not coping with 
the altitude and training. 
Reasons behind the varied performance response to LHTL 
training are probably multi-factorial however genetics may play a 
large part [38]. Studies have shown that a transcriptional factor, called 
a hypoxia-inducible factor (HIF), is essential in promoting cellular 
adaptation to changes in oxygen availability and regulating the 
hypoxic gene expression [39]. Under hypoxic conditions, the HIF-1α 
complex is stable, allowing for transcriptional activation and ultimate 
stimulation of proteins such as EPO [40] and vascular endothelial 
growth factor [41]. HIF-1α also moderates other physiological 
responses at altitude including glucose transport and glycolytic 
enzyme activity [42]. Conversely, the studies of Mason et al. (2004) 
and (2007) showed that under low-oxygen conditions glycolysis is the 
central source of anaerobic energy which is regulated by HIF-1α. It 
can be seen in HIF-1α knockout mice that loss of HIF-1α in skeletal 
muscle causes an adaptive response by shifting from glycolytic 
metabolism toward fatty acid oxidation leading to an increased 
capacity for endurance exercise [43,44]. We speculate that the non-
responders in this study probably sensitive to the hypoxic condition 
consequently produced more HIF-1α compared to responders which 
may have increased the reliance on glycolysis and subsequently 
increased RER during exercise. However, more research is required 
in this area since other researchers have been unable to identify 
Responders (n = 6) Non-Responders (n = 4) Chances that true differences  are substantiala
Day 1 Day 20 Day 1 Day 20 Difference; ± 90% CL % Qualitative inference
RPE 0 min 11.3 ± 1.6 12.2 ± 1.3 10.0 ± 0.8 12.5 ± 0.6 -1.4 ± 1.3 92 Likely
RPE 5 min 12.8 ± 1.6 13.0 ± 1.9 11.5 ± 1.3 13.0 ± 1.2 -0.9 ± 2.1 69 Unclear
RPE 10 min 13.5 ± 2.4 13.7 ± 1.8 12.8 ± 1.0 13.8 ± 1.0 -0.6 ± 1.4 57 Unclear
RPE cool down 10.0 ± 1.4 8.8 ± 1.2 8.5 ± 1.7 9.5 ± 1.3 -1.6 ± 1.2 96 Very likely
Data are mean ± SD.  RPE 0 min, rate of perceived exertion after 5 min warm up prior to 10-min submaximal cycle test; RPE 5 min, rate of perceived exertion at 5 min 
during to 10-min submaximal cycle test; RPE 10 min, rate of perceived exertion during last minute of 10-min submaximal cycle test; RPE cool down, rate of perceived 
exertion during last minute of 5 minute cool down after 10-min submaximal cycle test.  aBased on the smallest substantial change of 0.2 for all measures. ± 90% CL: 
add and subtract this number to the mean effect to obtain confidence limits for the true difference.
Table 4: Mean rates of perceived exertion at day 1 and day 20 in responders and non-responders before, during and after submaximal cycle test.
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genes that can be overwhelmingly linked to the individual variability 
observed in responders versus non-responders [10] and HIF-1α 
gene expression quantification is unable to predict poor and good 
responder-athletes to the LHTL model [11]. 
From this research it seems clear that athletes who respond to 
altitude are less stressed in terms of lower heart rate, V E and higher 
levels of arterial oxygen saturation during submaximal exercise. 
Athletes that are not responding seem to perceive themselves as being 
more fatigued, become less efficient (use more oxygen per watt), have 
more muscle soreness, and higher AMS scores, particularly over the 
first few days of altitude. It seems the non-responders are unable to 
adapt to the increased demand for oxygen required by the muscles 
during exercise at altitude, resulting in fatigue and poor performance 
adaptation. Possible confounding factors behind athletes who 
respond to altitude training and those that do not may be their iron 
stores. Clearly, there is the need for further studies to investigate 
possible mechanisms.
A limitation of this study is lack of a sea-level control group 
which does not allow us to distinguish whether the observed effects 
are due to the altitude or to the effect of training. Indeed, altitudes 
that are more common for such training (e.g. 2000-2500 m) may have 
been better at separating out clear differences between responders 
and non-responders, but such altitude training bases are unavailable 
in New Zealand. In addition, maximal testing (run or cycle) may 
have provided greater evidence for differences between the groups. 
However, we consider our observations are worthwhile given the lack 
of information on such groups (elite triathletes all ranked within the 
world top 100). Nevertheless, these results should remain speculative 
until further research is conducted in a more controlled study.
Conclusion 
This investigation demonstrated that changes in some simple 
measures taken during submaximal exercise (SpO2, HR, V E, economy 
and RPE) or at rest (perception of fatigue, muscle soreness, training 
performance and the acute mountain sickness score) during an 
altitude sojourn may be useful indicators for classifying athletes that 
are coping and are likely to improve subsequent sea-level performance 
from those that are suffering increased stress and are likely to decrease 
subsequent sea-level performance. These physiological indicators and 
subjective variables provide non-invasive screening for athletes who 
could profit from such hypoxic exposure. 
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